Skip to main content
Clinical Trials/ACTRN12616001691437
ACTRN12616001691437
Completed
Phase 4

High flow humidified nasal oxygen to prevent desaturation during EBUS – a randomised controlled trial

Royal Melbourne Hospital0 sites60 target enrollmentDecember 8, 2016

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Royal Melbourne Hospital
Enrollment
60
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 8, 2016
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria will be all of:
  • \- Adults aged greater than or equal to 18 years
  • \- Able to give informed consent
  • \- Planned for endobronchial ultrasound and
  • \- Planned for sedation for their endobronchial ultrasound

Exclusion Criteria

  • 1\. Unable to give informed consent
  • 2\. Intubated, or planned for intubation or general anaesthesia for their endobronchial ultrasound
  • 3\. Pregnant patients
  • 4\. Patients with active nasal bleeding or base of skull fracture
  • 5\. Non\-english speaking patients

Outcomes

Primary Outcomes

Not specified

Similar Trials